Nov 11, 2020
|
CEO Update: Getting the word out - OraGrowtH Trials
|
|
Nov 10, 2020
|
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
|
|
Oct 29, 2020
|
Lumos Pharma to Participate in November Investor Conferences
|
|
Oct 27, 2020
|
Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
|
|
Aug 27, 2020
|
Lumos Pharma to Participate in Upcoming Investor Conferences
|
|
Aug 13, 2020
|
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
|
|
Jul 30, 2020
|
CEO Update: Lumos Pharma’s COVID-19 Response and Clinical Progress
|
|
Jul 28, 2020
|
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
|
|
Jul 27, 2020
|
Lumos Pharma Announces Sale of Priority Review Voucher
|
|
May 28, 2020
|
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
|
|